Commercial cell therapy
Search documents
Cryoport outlines $190M–$194M 2026 revenue target as commercial cell therapy drives growth (NASDAQ:CYRX)
Seeking Alpha· 2026-03-04 04:42
Earnings Call InsightsCryoport outlines $190M–$194M 2026 revenue target as commercial cell therapy drives growthMar. 03, 2026 11:42 PM ETCryoport, Inc. (CYRX) StockAI-Generated Earnings Calls InsightsCommentsEarnings Call Insights: Cryoport, Inc. (CYRX) Q4 2025 Management View CEO Jerrell Shelton reported "full year revenue from continuing operations of $176.2 million, exceeding the high end of our prior guidance and reflecting continued momentum across our core markets." Shelton highlighted double-digit re ...